Literature DB >> 1491805

The dopamine D1 receptor antagonist SCH-23390 decreases the mRNA levels of the transcription factor zif268 (krox-24) in adult rat intact striatum--an in situ hybridization study.

P Mailleux1, F Zhang, J J Vanderhaeghen.   

Abstract

By in situ hybridization with an oligonucleotide probe, we have studied the cellular distribution of the messenger RNA encoding the transcription factor zif268 (krox-24) in the adult intact rat striatum and regulation of its synthesis by acute treatment with the dopamine D1 receptor antagonist SCH-23390. Zif268 mRNA was found in the striatal medium-sized neurons and not in the large cells. Its levels were decreased by SCH-23390, suggesting activation of this immediate early gene in the striatum through dopamine D1 receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491805     DOI: 10.1016/0304-3940(92)90590-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

Review 1.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

2.  Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum.

Authors:  Genevieve Beauvais; Subramaniam Jayanthi; Michael T McCoy; Bruce Ladenheim; Jean Lud Cadet
Journal:  Brain Res       Date:  2010-01-06       Impact factor: 3.252

3.  Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens.

Authors:  Regan Ashby; Peter Kozulin; Pam L Megaw; Ian G Morgan
Journal:  Mol Vis       Date:  2010-04-13       Impact factor: 2.367

4.  Dop1 enhances conspecific olfactory attraction by inhibiting miR-9a maturation in locusts.

Authors:  Xiaojiao Guo; Zongyuan Ma; Baozhen Du; Ting Li; Wudi Li; Lingling Xu; Jing He; Le Kang
Journal:  Nat Commun       Date:  2018-03-22       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.